Chemical Structure : KCL-286
CAS No.: 1952276-71-9
Catalog No.: PC-21838Not For Human Use, Lab Use Only.
KCL-286 (C286) is a potent, selective and orally bioavailable RARβ agonist with EC50 of 1.9 nM/26 nM/13 nM for RARβ/RARα/RARγ, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $198 | In stock | |
10 mg | $328 | In stock | |
25 mg | $548 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
KCL-286 (C286) is a potent, selective and orally bioavailable RARβ agonist with EC50 of 1.9 nM/26 nM/13 nM for RARβ/RARα/RARγ, respectively.
KCL-286 (C286) displays 5-23 fold selectivity for RARβ over RARα (23 fold) and for RARβ over RARγ (5 fold) against the human RAR ligand-binding domains.
KCL-286 (C286) possess a promising pharmacokinetic profile in both rat and dog.
KCL-286 (C286) increases neurite outgrowth in vitro and induce sensory axon regrowth in vivo in a rodent model of avulsion and crush injury.
M.Wt | 334.33 | |
Formula | C19H14N2O4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid |
1. Maria B Goncalves, et al. Bioorg Med Chem Lett. 2019 Apr 15;29(8):995-1000.
2. Maria B Goncalves, et al. Br J Clin Pharmacol. 2023 Dec;89(12):3573-3583.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright